Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma

British Journal of Cancer

Volumn 96, Issue 10, 2007, Pages 1569-1578

  Lemos Gonzalez Y ^a   Rodriguez Berrocal F J ^a   Cordero, O J ^b   Gomez C ^c   Paez De La Cadena M ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

Amphiregulin; Epidermal growth factor; Epidermal growth factor receptor; Head and neck carcinoma; Non small cell lung cancer; Transforming growth factor alpha

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; BLOOD CHEMISTRY; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; FEMALE; GENDER; HEAD AND NECK CARCINOMA; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; EPIDERMAL GROWTH FACTOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LIGANDS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANDROGEN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 34248590819     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603770     Document Type: Article

References (37)

1. Ayude D, Paez de la Cadena M, Cordero OJ, Nogueira M, Ayude J, Fernández-Briera A, Rodríguez-Berrocal FJ (2003-2004) Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer. Dis Markers 19: 267-272
2. Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Dachao L, Fishman DA, Podratz KC, Maihle NJ (2003) Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 12: 103-113
3. Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Nita JM (1999) Serum sErbB1 and epidermal growth factor levels as tumour biomarkers in women with stage III o IV epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 8: 129- 137
4. Baron AT, Lafky JM, Suman VJ, Hillman DW, Buenafe MC, Boardman CH, Podratz KC, Perz EA, Maihle NJ (2001) A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women. Cancer Epidemiol Biomark Prev 10: 1175-1185
5. Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7: 2-8
6. Carney WP, Burrell M, Morris LD, Hamer PJ (2002) Normal levels of serum EGFr and drecreases in several cancers. Proc AACR 43: 47
7. Casalini P, Iorio MV, Galmozzi E, Ménard S (2004) Role of HER receptors family in development and differentiation. J Cell Physiol 200: 343-350
8. Chakrabarty S, Huang S, Moskal TL, Fritsche HA (1994) Elevated serum levels of transforming growth factor-alpha in breast cancer patients. Cancer Lett 79: 157-160
9. Chien CH, Huang CC, Lin YH, Shen J, Chow SN (1997) Detection of serum transforming growth factor-alpha in patients of primary ovarian cancers by enzyme immunoassay. Gynecol Oncol 66: 405-410
10. Choi JH, Kim HC, Lim HY, Nam DK, Kim HS, Yi SY, Shim KS, Han WS (1999) Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients. Oncology 57: 236-241
11. Choi JH, Oh JY, Ryu SK, Kim SJ, Lee NY, Kim YS, Yi SY, Shim KS, Han WS (1997) Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer 79: 1879-1883
12. Cordero OJ, Ayude D, Nogueira M, Rodríguez-Berrocal FJ, Páez de la Cadena M (2000) Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer 83: 1139-1146
13. Efimova EA, Glanemann M, Nussier AK, Schumacher G, Settmacher U, Jonas S, Nussier N, Neuhaus P (2005) Changes in serum levels of growth factors in healthy individuals alter related liver donation. Transplant Proc 37: 1074-1075
14. Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, Faucher J, Posner MR (2005) Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 41: 70-76
15. Harada K, Shiota G, Kawasaki H (1999) Transforming growth factor-α and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma. Liver 19: 318-325
16. Hashimoto K, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Takei N, Iyo M (2005) No changes in serum epidermal growth factor levels in patients with schizophrenia. Psychiatry Res 135: 257-260
17. Hoffmann TK, Ballo H, Braunstein S, Van Lierop A, Wagenmann M, Bier H (2001) Serum level and tissue expression of c-erbB-1 and c-erbB-2 protooncogene products in patients with squamous cell carcinoma of the head and neck. Oral Oncol 37: 50- 56
18. Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y (2005) Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res 65: 9176-9184
19. Jimeno A, Hidalgo M (2005) Blockade of epidermal growth factor receptor (EGFR) activity. Crit Rev Oncol Hematol 53: 179-192
20. Kong YG, Ren ZY, Su CB, Wang RZ, Ma WB, Lian W (2004) Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma. Chin Med Sci J 19: 199-202
21. Konturek A, Barczynsky M, Cichon S, Pituch-Noworolska A, Jonkisz J, Cichon W (2005) Significance of vascular endothelial growth factor and epidermal growth factor in development of papillary thyroid cancer. Langenbecks Arch Surg 390: 216-221
22. Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR (2004) Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol 22: 4575-4583
23. Markopoulos AK, Belazi M, Drakoulakos D, Petrou-Americanou C, Sioulis A, Sakellari D, Papanayotou P (2001) Epidermal growth factor receptor in saliva and serum of patients with cyclosporin-induced gingival overgrowth. J Periodontal Res 36: 88-91
24. Meggiato T, Plebani M, Basso D, Panozzo MP, Del Favero G (1999) Serum growth factors in patients with pancreatic cancer. Tumor Biol 20: 65-71
25. Mendelsohn J, Baselga J (2006) Epidermal growth factor receptor targeting in cancer. Semin Oncol 33: 369-385
26. Moskal TL, Huang S, Ellis LM, Fritsche HA, Chakrabarty S (1995) Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev 4: 127-131
27. Nedvídková J, Nemec J, Stolba P, Vavrejnova V, Bednar J (1992) Epidermal growth factor (EGF) in serum of patients with differentiated carcinoma of thyroids. Neoplasma 39: 11-14
28. Oh MJ, Choi JH, Kim IO, Lee YH, Huh JY, Park YK, Lee KW, Chough SY, Joo KS, Ku BS, Saw H-S (2000) Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma. Clin Cancer Res 6: 4760-4763
29. Ramesh Kumar R, Meenakshi A, Sivakumar N (2001) Enzyme immunoassay of human epidermal growth factor receptor (hEGFR). Hum Antibodies 10: 143-147
30. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ (1998) Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90: 824-832
31. Sasaki H, Yukiue H, Mizuno K, Sekimura A, Konishi A, Yano M, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y (2003) Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Int J Clin Oncol 8: 79-82
32. Sasaki H, Yukiue H, Sekimura A, Mizuno K, Konishi A, Yano M, Fukai I, Fujii Y (2004) Elevated serum epidermal growth factor receptor level in stage IV thymoma. Surg Today 34: 477-479
33. Schneider J, Presek P, Braun A, Bauer P, Konietzko N, Wiesner B, Woitowitz HJ (1999) p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. Br J Cancer 80: 1987-1994
34. Shim KS, Kim KH, Park BW, Yi SY, Choi JH, Han WS, Park EB (1998) Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer. Dis Colon Rectum 41: 219-224
35. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast Jr RC (2004) Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol 22: 4059-4066
36. Sobin LH, Wittekind C (2002) TNM Classification on Malignat Tumours, 6th edn. Wiley: New York
37. Tomiya T, Fujiwara K (1996) Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrosis. Cancer 77: 1056-1060